Clinical Trial Update: Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, pharmacokinetics, and tolerability of BMS-708163 in Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• BMS-708163

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED